- Home
- Publications
- Publication Search
- Publication Details
Title
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-15
DOI
10.3389/fcimb.2022.823684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mobile Carbapenemase Genes in Pseudomonas aeruginosa
- (2021) Eun-Jeong Yoon et al. Frontiers in Microbiology
- Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model
- (2021) Mao Hagihara et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan
- (2021) Shu-Chen Kuo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review
- (2021) Hsin-Yu Chen et al. Frontiers in Cellular and Infection Microbiology
- Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018
- (2021) Shio-Shin Jean et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
- (2021) Po-Yu Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Global Distribution Patterns of Carbapenemase-Encoding Bacteria in a New Light: Clues on a Role for Ethnicity
- (2021) Claudio Neidhöfer et al. Frontiers in Cellular and Infection Microbiology
- Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
- (2021) Adam B. Shapiro et al. Frontiers in Microbiology
- Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China
- (2021) Kai Yang et al. Journal of Global Antimicrobial Resistance
- Susceptibility to Imipenem/Relebactam of Pseudomonas aeruginosa and Acinetobacter baumannii Isolates from Chinese Intra-Abdominal, Respiratory and Urinary Tract Infections: SMART 2015 to 2018
- (2021) Hui Zhang et al. Infection and Drug Resistance
- Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstream infection in Taiwan, 2020
- (2021) Shio-Shin Jean et al. Expert Review of Anti-Infective Therapy
- Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review
- (2021) Mihret Tilahun et al. Infection and Drug Resistance
- Meropenem/Vaborbactam versus Ceftazidime/Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
- (2020) Renee Ackley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019
- (2020) Lara Tavoschi et al. Eurosurveillance
- In vitro efficacy of Imipenem-Relebactam and Cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
- (2020) L. Tselepis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae
- (2020) Chi-Chung Chen et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Oral colonisation by antimicrobial-resistant Gram-negative bacteria among long-term care facility residents: prevalence, risk factors, and molecular epidemiology
- (2020) Mi Nguyen-Tra Le et al. Antimicrobial Resistance and Infection Control
- Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia
- (2020) Shio-Shin Jean et al. Journal of Clinical Medicine
- Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016: Five years of experience with an internal registry
- (2020) Adriana Jimenez et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Structural basis of reduced susceptibility to ceftazidime–avibactam and cefiderocol in Enterobacter cloacae due to AmpC R2 loop deletion
- (2020) Akito Kawai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments
- (2020) Anna Olsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multispecies Outbreak of Verona Integron-Encoded Metallo-ß-Lactamase-Producing Multidrugresistant Bacteria Driven by a Promiscuous Incompatibility Group A/C2
- (2020) Tom J B de Man et al. CLINICAL INFECTIOUS DISEASES
- Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination
- (2020) Andrea Novelli et al. Expert Review of Anti-Infective Therapy
- In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China
- (2020) Xiaojuan Wang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rapid identification of bloodstream bacterial and fungal pathogens and their antibiotic resistance determinants from positively flagged blood cultures using the BioFire FilmArray blood culture identification panel
- (2020) Chun-Min Kang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Antimicrobial resistance comparison of Klebsiella pneumoniae pathogens isolated from intra-abdominal and urinary tract infections in different organs, hospital departments and regions of China between 2014 and 2017
- (2020) Hui Zhang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Molecular epidemiology and resistance patterns of blaOXA-48 Klebsiella pneumoniae and Escherichia coli: A nationwide multicenter study in Taiwan
- (2020) Ching-Hsun Wang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems
- (2020) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital
- (2020) Zhongliang Duan et al. BMC MICROBIOLOGY
- An evaluation of meropenem + vaborbactam for the treatment of nosocomial pneumonia
- (2020) Lauren M. Groft et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Clinical and Microbiological Characteristics of Community-Onset Carbapenem-Resistant Enterobacteriaceae Isolates
- (2020) Hangbin Hu et al. Infection and Drug Resistance
- Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019
- (2020) Helio S Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High mortality by nosocomial infections caused by carbapenem-resistant P. aeruginosa in a referral hospital in Brazil: facing the perfect storm
- (2020) Jane Eire Urzedo et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Prevalence of carbapenem-resistant Enterobacteriaceae and emergence of high rectal colonization rates of blaOXA-181-positive isolates in patients admitted to two major hospital intensive care units in Kuwait
- (2020) Amani H. Al Fadhli et al. PLoS One
- In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa: Results from a Multicenter Study in China, 2017
- (2019) Dandan Yin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The new perspective of old antibiotic: In vitro antibacterial activity of TMP-SMZ against Klebsiella pneumoniae
- (2019) Jiahui Li et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Carbapenem-resistant Acinetobacterbaumannii: in pursuitof an effective treatment
- (2019) Evangelia-Theophano Piperaki et al. CLINICAL MICROBIOLOGY AND INFECTION
- The SHIELD Orange County Project –Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California
- (2019) James A McKinnell et al. CLINICAL INFECTIOUS DISEASES
- Beyond piperacillin-tazobactam: cefepime and AAI101 as a potent β-lactam-β-lactamase inhibitor combination
- (2019) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of cefepime-enmetazobactam against Gram-negative isolates collected from United States and European hospitals during 2014-2015
- (2019) Ian Morrissey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
- (2019) Shio-Shin Jean et al. DRUGS
- High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of disease
- (2019) Dien M. Tran et al. JOURNAL OF INFECTION
- Imipenemase-producing carbapenem-resistant Enterobacteriaceae transmission in a long-term-care facility during a community-wide multidrug resistant organism outbreak—North Carolina, 2017
- (2019) Heather Dubendris et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC
- (2019) Melissa D. Barnes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of outer membrane permeability, efflux mechanism, and carbapenemases in carbapenem-nonsusceptible Pseudomonas aeruginosa from Dubai hospitals: Results of the first cross-sectional survey
- (2019) Carole Ayoub Moubareck et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Dual β-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition
- (2019) Thanyaluck Siriyong et al. Scientific Reports
- Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
- (2019) Basem M. Alraddadi et al. BMC INFECTIOUS DISEASES
- Bronchoscope-Related “Superbug” Infections
- (2019) Atul C. Mehta et al. CHEST
- Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study
- (2019) Melissa G McCracken et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae
- (2019) Maria Loose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
- (2019) Patrice Nordmann et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria
- (2019) Yoshinori Yamano CLINICAL INFECTIOUS DISEASES
- Meropenem–nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection model
- (2019) Tomefa E. Asempa et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
- (2019) Lei Wang et al. Frontiers in Microbiology
- Heteroresistance to colistin in oxacillinases-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran
- (2019) Fereshteh Ezadi et al. Journal of Global Antimicrobial Resistance
- Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae
- (2019) Kayoko Hayakawa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resistance to Ceftazidime-Avibactam and Underlying Mechanisms
- (2019) Yuhang Wang et al. Journal of Global Antimicrobial Resistance
- Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany
- (2019) Elena Schäfer et al. Antimicrobial Resistance and Infection Control
- Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group
- (2018) Hideharu Hagiya et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Colonization of long-term care facility residents in three Italian Provinces by multidrug-resistant bacteria
- (2018) Elisabetta Nucleo et al. Antimicrobial Resistance and Infection Control
- Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
- (2018) Gowri Raman et al. Antimicrobial Resistance and Infection Control
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015–17)
- (2018) Helio S Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates
- (2018) Pranita D. Tamma et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis
- (2018) Eliseth Costa Oliveira de Matos et al. Revista da Sociedade Brasileira de Medicina Tropical
- New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
- (2018) Burcu Isler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
- (2018) Shun-Chung Hsueh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae
- (2018) Shazad Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
- (2018) Shio-Shin Jean et al. Frontiers in Microbiology
- Prevalence of different carbapenemase genes among carbapenem-resistant Acinetobacter baumannii blood isolates in Taiwan
- (2018) Teng-Ho Wang et al. Antimicrobial Resistance and Infection Control
- The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
- (2018) Effat Davoudi-Monfared et al. Infection and Drug Resistance
- In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
- (2018) Shio-Shin Jean et al. Infection and Drug Resistance
- Appropriate treatment for bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae and Escherichia coli: A nationwide multicenter study in Taiwan
- (2018) Yi-Tsung Lin et al. Open Forum Infectious Diseases
- Epidemiology of Carbapenem-Resistant Enterobacteriaceae at a Long-term Acute Care Hospital
- (2018) Teena Chopra et al. Open Forum Infectious Diseases
- Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients
- (2017) L. Lapointe-Shaw et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Healthcare Antibiotic Resistance Prevalence – DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia
- (2017) Jacqueline Reuben et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Carbapenem-resistant Enterobacteriaceae in the community: a scoping review
- (2017) Ana M. Kelly et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
- (2017) Kirati Kengkla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
- (2017) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rapid Detection of Carbapenemases in Enterobacteriaceae: Evaluation of the Resist-3 O.K.N. (OXA-48, KPC, NDM) Lateral Flow Multiplexed Assay
- (2017) David W. Wareham et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan
- (2017) Chun-Ming Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Update on fosfomycin-modified genes in Enterobacteriaceae
- (2017) Tsung-Ying Yang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting
- (2017) Abdul Rahman Zaidah et al. Antimicrobial Resistance and Infection Control
- Prevalence and drug resistance characteristics of carbapenem-resistant Enterobacteriaceae in Hangzhou, China
- (2017) Yan Yang et al. Frontiers of Medicine
- Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
- (2017) Rong Zhang et al. EBioMedicine
- Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
- (2017) Thomas Howe McConville et al. PLoS One
- Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors
- (2016) Cheston B. Cunha et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City
- (2016) Nishant Prasad et al. AMERICAN JOURNAL OF INFECTION CONTROL
- A prolonged outbreak of KPC-3-producing Enterobacter cloacae and Klebsiella pneumoniae driven by multiple mechanisms of resistance transmission at a large academic burn center
- (2016) Hajime Kanamori et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan
- (2016) Cheng-Yen Kao et al. BMC MICROBIOLOGY
- Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-ResistantEnterobacteriaceaeBacteremia
- (2016) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
- (2016) Tamar F. Barlam et al. CLINICAL INFECTIOUS DISEASES
- Multidrug-Resistant Bacteria in the Community
- (2016) David van Duin et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa
- (2016) Martin Vestergaard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Genomic islands 1 and 2 carry multiple antibiotic resistance genes in Pseudomonas aeruginosa ST235, ST253, ST111 and ST175 and are globally dispersed
- (2016) Piklu Roy Chowdhury et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
- (2016) Zaira R. Palacios-Baena et al. JOURNAL OF INFECTION
- Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin
- (2016) Hung-Jen Tang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
- (2016) Shio-Shin Jean et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
- (2016) Belén Gutiérrez-Gutiérrez et al. MAYO CLINIC PROCEEDINGS
- Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?
- (2016) Sandra S. Richter et al. Virulence
- Multilocus Sequence Typing Analysis of Carbapenem-Resistant Acinetobacter baumannii in a Chinese Burns Institute
- (2016) Guangtao Huang et al. Frontiers in Microbiology
- Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
- (2016) Sami Abdellatif et al. Annals of Intensive Care
- Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009)
- (2016) David P. Kateete et al. SpringerPlus
- Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates
- (2016) Hung-Jen Tang et al. PLoS One
- In VitroActivity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013
- (2015) Douglas J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa – an update
- (2015) Michelle Lowings et al. BMC INFECTIOUS DISEASES
- Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia
- (2015) Aristine Cheng et al. CRITICAL CARE MEDICINE
- Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections
- (2015) Warren Lowman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)
- (2015) KE Goodman et al. Expert Review of Anti-Infective Therapy
- Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options
- (2015) Shio-Shin Jean et al. Future Microbiology
- The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents
- (2015) John P Mills et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Prevalence of and Risk Factors for Multidrug-Resistant Acinetobacter baumannii Colonization Among High-Risk Nursing Home Residents
- (2015) Lona Mody et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital
- (2015) B. Semin-Pelletier et al. JOURNAL OF HOSPITAL INFECTION
- Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
- (2015) Diana P. Pires et al. JOURNAL OF VIROLOGY
- Pediatric Carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a High-prevalence Region in the United States
- (2015) Pia S. Pannaraj et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Antimicrobial resistance profiles and oxacillinase genes in carbapenem-resistant Acinetobacter baumannii isolated from hospitalized patients in Santa Catarina, Brazil
- (2015) Giselle Dall Cortivo et al. Revista da Sociedade Brasileira de Medicina Tropical
- Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital
- (2015) Yaowen Chang et al. Frontiers in Microbiology
- Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital
- (2015) Faten M. Elabd et al. Journal of Infection and Public Health
- Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration
- (2014) S. W. S. Yapa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Systematic Review and Meta-Analyses Show that Carbapenem Use and Medical Devices Are the Leading Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa
- (2014) A. F. Voor in 't holt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An outbreak of extremely drug-resistant Pseudomonas aeruginosain a tertiary care pediatric hospital in Italy
- (2014) Marta Ciofi degli Atti et al. BMC INFECTIOUS DISEASES
- Treating infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) L.S. Tzouvelekis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review
- (2014) P. Poulikakos et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Spread of Klebsiella pneumoniae carbapenemase-2-producing Klebsiella pneumoniae clones in Asia
- (2014) Shio-Shin Jean et al. Future Microbiology
- Risk Factors for Colonization due to Carbapenem-Resistant Enterobacteriaceae among Patients: Exposed to Long-Term Acute Care and Acute Care Facilities
- (2014) Ashish Bhargava et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Statewide Surveillance of Carbapenem-Resistant Enterobacteriaceae in Michigan
- (2014) Brenda M. Brennan et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Epidemiology of Metalloenzyme-ProducingPseudomonas aeruginosain a Tertiary Hospital in Greece
- (2014) S. Zappas et al. JOURNAL OF CHEMOTHERAPY
- CarbAcineto NP Test for Rapid Detection of Carbapenemase-Producing Acinetobacter spp.
- (2014) L. Dortet et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Code blue:Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity
- (2014) A.M. Richards et al. Molecular Oral Microbiology
- Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship
- (2014) Young Kyung Yoon et al. PLoS One
- Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae
- (2013) Milena McLaughlin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Importance of Long-term Acute Care Hospitals in the Regional Epidemiology of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae
- (2013) Michael Y. Lin et al. CLINICAL INFECTIOUS DISEASES
- KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality
- (2013) Matthaios Papadimitriou-Olivgeris et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case–control analysis
- (2013) C. Lübbert et al. INFECTION
- Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: Results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009
- (2013) Shio-Shin Jean et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
- (2013) Mark Bounthavong et al. Infection and Drug Resistance
- The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
- (2012) Meredith G. Jernigan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
- (2012) Laura Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
- (2012) J. S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Outbreak of Carbapenem-Resistant Enterobacteriaceae at a Long-Term Acute Care Hospital: Sustained Reductions in Transmission through Active Surveillance and Targeted Interventions
- (2012) Amit S. Chitnis et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Comparative Evaluation of a Prototype Chromogenic Medium (ChromID CARBA) for Detecting Carbapenemase-Producing Enterobacteriaceae in Surveillance Rectal Swabs
- (2012) Georgia Vrioni et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparison of Four Chromogenic Culture Media for Carbapenemase-Producing Enterobacteriaceae
- (2012) K. M. Wilkinson et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit - a systematic review of risk factors and environmental sources
- (2012) J. M. C. Jefferies et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients
- (2012) Jayant S. Kalpoe et al. LIVER TRANSPLANTATION
- Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients
- (2012) Ryan K. Shields et al. PLoS One
- Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae
- (2011) Abraham Borer et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
- (2011) N. Gupta et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel
- (2011) Debby Ben-David et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
- (2011) Marie Kempf et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes
- (2011) Y.-C. Lee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combination Antibiotic Therapy for Empiric and Definitive Treatment of Gram-Negative Infections: Insights from the Society of Infectious Diseases Pharmacists
- (2011) Natalie Boyd et al. PHARMACOTHERAPY
- Contribution of a Plasmid-Borne blaOXA-58 Gene with Its Hybrid Promoter Provided by IS1006 and an ISAba3-Like Element to -Lactam Resistance in Acinetobacter Genomic Species 13TU
- (2010) T.-L. Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug‐ResistantAcinetobacter baumannii:An Emerging Pathogen among Older Adults in Community Hospitals and Nursing Homes
- (2010) D. M. Sengstock et al. CLINICAL INFECTIOUS DISEASES
- Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals
- (2010) Jie Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli
- (2010) Sho Takahata et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases
- (2010) Constantinos C. Papagiannitsis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
- (2010) Wang-Huei Sheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Sequence types of Portuguese carbapenem-resistant Acinetobacter baumannii isolates collected over 10 years
- (2010) G. J. Da Silva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- Impact of multidrug-resistantPseudomonas aeruginosainfection on patient outcomes
- (2010) Elizabeth B Hirsch et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases
- (2009) P. Giakkoupi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature
- (2009) Matthew E Falagas et al. Future Microbiology
- Risk Factors for Mortality in Patients with Nosocomial Stenotrophomonas maltophilia Pneumonia
- (2009) Chia-Cheng Tseng et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
- (2009) Abraham Borer et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- A Stenotrophomonas maltophilia Multilocus Sequence Typing Scheme for Inferring Population Structure
- (2009) S. Kaiser et al. JOURNAL OF BACTERIOLOGY
- The Emerging Threat of Multidrug-Resistant Gram-Negative Organisms in Long-Term Care Facilities
- (2009) E. O'Fallon et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started